Delivery Order 75N92019D00016-75N92019F00074
Award Date
12/19/18
Potential Completion Date
12/18/23
Potential Value
$1.7M
Federal Agency
National Heart Lung and Blood Institute
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
Philadelphia, PA 19104, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a civilian agency, to The Trustees of the University of Pennsylvania (Penn) to support the Gene Therapy Resource Program (GTRP). The $1,671,379.55 cost-no-fee contract is for Penn's Preclinical Vector Core Laboratory to provide scientific activities related to gene therapy. The award has a completion date of July 5, 2024 and does not have a set-aside designation. Penn is a leading private research university...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Delivery Order to The Trustees of the University of Pennsylvania (Penn) on August 23, 2019 with a potential value of $1,408,152.00 for "TASK AREA B: PRE-CLINICAL VECTOR CORE LABORATORY SCIENTIFIC ACTIVITIES" under the Gene Therapy Resource Program (GTRP). This is a Cost No Fee contract with a completion date of September 22, 2021. Penn is a private university...
This is a firm-fixed price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a civilian agency, to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The $14,917.20 contract is for gene therapy vector services to support NICHD's research objectives. The contract does not have a set-aside designation, reflecting the university's status as a large research institution....
The National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $18,371.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is for the NHLBI's DIR Graft Lungevity Study, which requires obtaining samples and data. The contract has an ultimate completion date of August 31, 2025 and was awarded on September...
The U.S. National Heart Lung and Blood Institute (NHLBI) awarded a $598,672.91 cost-plus-fixed-fee task order contract to The Children's Hospital of Philadelphia (CHOP) for the Gene Therapy Resource Program (GTRP) AAV Vector Production Core Lab. This task order, which is part of a larger GTRP program, has a period of performance through May 31, 2017 and a current funding level of $325,007. The contract does not have a set-aside designation. CHOP, a leading pediatric hospital and research...
The Department of Health and Human Services National Institutes of Health National Human Genome Research Institute awarded a $15,143 firm fixed price purchase order to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. The contract is to be performed in Philadelphia, Pennsylvania over a one day period from July 24, 2023 through July 24, 2023. No additional details were provided on products or services requested under the...
The National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health, has awarded a $21,072.00 firm-fixed-price purchase order contract to The Trustees of the University of Pennsylvania, doing business as the Clinical Practices of the University of Pennsylvania. The contract is for the production of MAXI DNA constructs containing the EF1a promoter, human SirT3-3xFLAG, and WPRE and BGH elements. The contract has an ultimate completion date of August 31,...
This federal contract award was issued by the Food and Drug Administration (FDA) to The Trustees of The University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania, for a firm fixed-price delivery order. The contract, valued at $1,268.22, is to provide expertise and support for communications and an annual meeting related to the FDA's epidemiology research. The contract has no set-aside designation. The University of Pennsylvania is a prestigious private...
The Department of Health and Human Services' National Institutes of Health National Human Genome Research Institute awarded a $23,040 purchase order to The Trustees of the University of Pennsylvania, doing business as Clinical Practices of the University of Pennsylvania. Under this firm fixed price contract, the University of Pennsylvania will provide plasmid DNA sequence analysis services without structural information for Plasmid 5. The place of performance is Philadelphia, Pennsylvania. ...
This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health to the Trustees of the University of Pennsylvania, operating as the University of Pennsylvania, to conduct biomedical research, data analysis, and other scientific activities supporting public health objectives. The $885,000.00 contract is a definitive contract with a time and materials pricing type, with a completion date of March 15, 2005. The contract does not have a set-aside...